mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.0006 |
mRNA |
YK 4-279 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0006 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0007 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.0008 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0008 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.0009 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tivantinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.001 |